Navigation Links
Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future
Date:10/6/2011

NEW YORK, Oct. 6, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

http://www.reportlinker.com/p0652042/Contraceptives-Market-to-2017---Hormonal-Contraceptives-and-Strong-Pipeline-to-Drive-the-Growth-in-Future.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

Summary

GBI Research, the leading business intelligence provider, has released its latest research, "Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future" which provides insights into the global contraceptives market and market forecasts until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts. The report provides an in-depth analysis of the contraceptives most commonly used, such as oral, topical and injectable contraceptives, intrauterine devices, condoms and vaginal rings. The report also examines usage patterns for oral, topical and injectable contraceptives treatment. It also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape, including major companies in the contraceptives market. Finally, the report also includes analysis of mergers and acquisitions (M&A) and licensing agreements that have taken place in the global contraceptives market.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts.

GBI Research analysis shows that revenues are projected to increase from $15.5 billion in 2010 to $19.2 in 2017 at a CAGR of 3.1%. Prescription and OTC contraceptives held an 82% and 18% market share, respectively, in 2010. The intrauterine devices market was valued at $1,370.4m in 2010 and revenues are projected to increase to $1,398.1m in 2017, at a CAGR of 0.3%. However, revenues are expected to decline in 2015 due to the patent expiry of Mirena and the availability of low cost hormonal intrauterine devices. Strategic consolidations through acquisition accounted for 31% of M&A deals.

Scope

- The report analyzes the market characterization, pipeline analysis and key M&A trends for oral, topical and injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market.

- Data and analysis on the contraceptives market in leading geographies: the US, the UK, Germany, France, Italy, Spain and Japan.

- Annualized market data for oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 2002–2010, with forecasts to 2017.

- Market data on the therapeutic landscape, which covers oral, topical and injectable contraceptives, and includes market revenues, treatment usage patterns and annual cost of usage.

- Key drivers and restraints that have had a significant impact on the market.

- The competitive landscape of the contraceptives market, which includes companies such as Bayer, Johnson & Johnson, Reckitt Benckiser, Church & Dwight and Merck.

- Key M&A activities and licensing agreements that took place from 2005–2011 in the contraceptives market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

- Align your product portfolio to markets with high growth potential.

- Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.

- Devise a more tailored country strategy through understanding of key drivers and barriers in the contraceptives market.

- Develop key strategic initiatives by understanding the key focus areas of leading companies.

- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 7

2 Contraceptives Market to 2017- Introduction 9

2.1 GBI Research Report Guidance 10

3 Contraceptives Market to 2017 - Market Overview 11

3.1 Introduction 11

3.2 Revenue Forecasts for Contraceptives Market 11

3.2.1 Revenues 11

3.2.2 Annual Cost of Usage for Contraceptives 14

3.2.3 Share of Prescription and OTC Contraceptives 15

3.3 Drivers and Barriers for Contraceptives Market 16

3.3.1 Drivers for Contraceptives 16

3.3.2 Barriers for Contraceptives 16

4 Contraceptives Market to 2017- Geographical Landscape 17

4.1 The US 17

4.1.1 Revenue 17

4.1.2 Annual Cost of Therapy for Contraceptives 18

4.2 Top Five Countries of Europe 19

4.2.1 Revenue 19

4.2.2 Annual Cost of Therapy for Contraceptives 20

4.3 Japan 21

4.3.1 Revenue 21

4.3.2 Annual Cost of Therapy for Contraceptives 22

5 Contraceptives Market to 2017 - Therapeutic landscape 23

5.1 Oral Contraceptives 23

5.1.1 Introduction 23

5.1.2 Revenue 23

5.1.3 Annual Cost of Therapy 26

5.1.4 Treatment Usage Patterns 27

5.2 Injectables 29

5.2.1 Introduction 29

5.2.2 Revenue 29

5.2.3 Annual Cost of Therapy 32

5.2.4 Treatment Usage Patterns 33

5.3 Topical Contraceptives 35

5.3.1 Introduction 35

5.3.2 Revenue 35

5.3.3 Annual Cost of Therapy 38

5.3.4 Treatment Usage Patterns 39

6 Contraceptives Market to 2017 - Devices landscape 41

6.1 Vaginal Ring 41

6.1.1 Introduction 41

6.1.2 Revenue 41

6.1.3 Geographical Segmentation 43

6.1.4 Annual Cost of Usage 45

6.2 Intrauterine Devices 46

6.2.1 Introduction 46

6.2.2 Revenue 46

6.2.3 Copper Intrauterine Device and Hormonal Intrauterine Device Share 47

6.2.4 Geographical Segmentation 48

6.2.5 Annual Cost of Usage 50

6.3 Condoms 51

6.3.1 Introduction 51

6.3.2 Revenue 51

6.3.3 Geographical Segmentation 52

6.3.4 Annual Cost of Usage 54

7 Contraceptives Market to 2017 - Pipeline Analysis 55

7.1 Introduction 55

7.2 Profiles of Promising Drugs in the Global Contraceptives Market 58

7.2.1 AG200-15 58

7.2.2 Yaz Flex 58

7.2.3 Pill-Plus 59

8 Contraceptives Market to 2017 - Competitive Landscape 60

8.1 Market Share Analysis: Contraceptives Market 60

8.2 Drug Profile of Major Marketed Contraceptives 60

8.2.1 Yaz/ Yasmin 61

8.2.2 Mirena 61

8.2.3 Nuvaring 61

8.3 Competitive Profiling 62

8.3.1 Bayer 62

8.3.2 Johnson & Johnson 64

8.3.3 Church & Dwight 65

8.3.4 Merck 66

8.3.5 Reckitt & Benckiser 67

9 Contraceptives Market to 2017 - M&A Landscape 68

9.1 M&A Landscape 68

9.1.1 M&A Deals by Year 68

9.1.2 M&A Deals by Value 69

9.1.3 M&A Deals by Geography 70

9.1.4 M&A Deals by Deal Type 71

9.1.5 M&A Deals by Deal Sub-Type 72

9.2 R&D Licensing Agreements 73

9.2.1 Deals by Year 73

9.2.2 Deals by Geography 74

9.2.3 Deals by Value 75

9.3 Co-Development Agreements 76

9.3.1 Deals by Year 76

9.3.2 Deals by Geography 76

10 Contraceptives Market to 2017 - Appendix 77

10.1 Market Definitions 77

10.2 Abbreviations 77

10.3 Research Methodology 77

10.3.1 Coverage 77

10.3.2 Secondary Research 78

10.3.3 Primary Research 78

10.3.4 Section Methodology 78

10.3.5 Expert Panel Validation 80

10.4 Contact Us 80

10.5 Disclaimer 80

10.6 Sources 80

1.1 List of Tables

Table 1: Contraceptives Market, Global, Revenue, ($bn), 2002 - 2010 11

Table 2: Contraceptives Market, Global, Revenue Forecasts, ($bn), 2010 - 2017 11

Table 3: Contraceptives Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010 12

Table 4: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017 13

Table 5: Contraceptives Market, Global, Annual Cost of Usage, ($), 2002 - 2010 14

Table 6: Contraceptives Market, Global, Annual Cost of Usage, ($), 2010 - 2017 14

Table 7: Contraceptives Market, The US, Revenue, ($bn), 2002 - 2010 17

Table 8: Contraceptives Market, The US, Revenue Forecasts, ($bn), 2010 - 2017 17

Table 9: Contraceptives Market, The US, Annual Cost of Usage, ($), 2002 - 2010 18

Table 10: Contraceptives Market, The US, Annual Cost of Usage, ($), 2010 - 2017 18

Table 11: Contraceptives Market, Top Five Countries of Europe, Revenue, ($bn), 2002 - 2010 19

Table 12: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts, ($bn), 2010 - 2017 19

Table 13: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2002 - 2010 20

Table 14: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2010 - 2017 20

Table 15: Contraceptives Market, Japan, Revenue, ($m), 2002 - 2010 21

Table 16: Contraceptives Market, Japan, Revenue Forecasts, ($m), 2010 - 2017 21

Table 17: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2002 - 2010 22

Table 18: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2010 - 2017 22

Table 19: Oral Contraceptives Market, Global, Revenue, ($m), 2002 - 2010 23

Table 20: Oral Contraceptives Market, Global, Revenue Forecasts, ($m), 2010 - 2017 23

Table 21: Oral Contraceptives Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010 24

Table 22: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017 25

Table 23: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2010 26

Table 24: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2010 - 2017 26

Table 25: Oral Contraceptives Market, Global, Treatment Usage Patterns, (Million), 2002 - 2010 27

Table 26: Oral Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (Million), 2010 - 2017 28

Table 27: Injectables Market, Global, Revenue, ($m), 2002 - 2010 29

Table 28: Injectables Market, Global, Revenue Forecasts, ($m), 2010 - 2017 29

Table 29: Injectables Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010 30

Table 30: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017 31

Table 31: Injectables Market, Global, Annual Cost of Therapy, ($), 2002 - 2010 32

Table 32: Injectables Market, Global, Annual Cost of Therapy, ($), 2010 - 2017 32

Table 33: Injectables Market, Global, Treatment Usage Patterns, ('000), 2002 - 2010 33

Table 34: Injectables Market, Global, Treatment Usage Patterns Forecasts, ('000), 2010 - 2017 34

Table 35: Topical Contraceptives Market, Global, Revenue, ($m), 2002 - 2010 35

Table 36: Topical Contraceptives Market, Global, Revenue Forecasts, ($m), 2010 - 2017 35

Table 37: Topical Contraceptives Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010 36

Table 38: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017 37

Table 39: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2010 38

Table 40: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2010 - 2017 38

Table 41: Topical Contraceptives Market, Global, Treatment Usage Patterns, ('000), 2002 - 2010 39

Table 42: Topical Contraceptives Market, Global, Treatment Usage Patterns, ('000), 2010 - 2017 40

Table 43: Vaginal Ring Market, Global, Revenue, ($m), 2002 - 2010 41

Table 44: Vaginal Ring Market, Global, Revenue Forecasts, ($m), 2010 - 2017 42

Table 45: Vaginal Ring Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010 43

Table 46: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017 44

Table 47: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2002 - 2010 45

Table 48: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2010 - 2017 45

Table 49: Intrauterine Devices Market, Global, Revenue, ($m), 2002 - 2010 46

Table 50: Intrauterine Devices Market, Global, Revenue Forecasts, ($m), 2010 - 2017 47

Table 51: Intrauterine Devices Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010 48

Table 52: Intrauterine Devices Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017 49

Table 53: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2002 - 2010 50

Table 54: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2010 - 2017 50

Table 55: Condoms Market, Global, Revenue, ($m), 2002 - 2010 51

Table 56: Condoms Market, Global, Revenue Forecasts, ($m), 2010 - 2017 51

Table 57: Condoms Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010 52

Table 58: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017 53

Table 59: Condoms Market, Global, Annual Cost of Usage, ($), 2002 - 2010 54

Table 60: Condoms Market, Global, Annual Cost of Usage, ($), 2010 - 2017 54

Table 61: Contraceptives Market, Global, Product Pipeline by Phase, 2011 55

Table 62: Contraceptives Market, Global, Pipeline, Pre-Clinical Stage Molecules, 2011 56

Table 63: Contraceptives Market, Global, Pipeline, Discovery Stage Molecules, 2011 56

Table 64: Contraceptives Market, Global, Pipeline, Phase I Molecules, 2011 56

Table 65: Contraceptives Market, Global, Pipeline, Phase II Molecules, 2011 56

Table 66: Contraceptives Market, Global, Pipeline, Phase III Molecules, 2011 57

Table 67: Contraceptives Market, Global, Pipeline, NDA Filed Molecules, 2011 57

Table 68: Contraceptives Market, Global, Revenues of Major Marketed Contraceptives, ($m), 2010 60

Table 69: Contraceptives Market, Global, M&A Deals by Value, 2000 - 2011 69

Table 70: Contraceptives Market, Global, M&A Deals by Geography, 2000 - 2011 70

Table 71: Contraceptives Market, Global, M&A Deals by Deal Type, 2000 - 2011 71

Table 72: Contraceptives Market, Global, Deals by Deal Sub-Type, 2000 - 2011 72

Table 73: Contraceptives Market, Global, Licensing Agreements by Geography, 2004 - 2011 74

Table 74: Contraceptives Market, Global, Licensing Agreements by Value, 2004 - 2011 75

1.2 List of Figures

Figure 1: Contraceptives Market, Global, Revenue Forecasts, ($bn), 2002 - 2017 11

Figure 2: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($bn), 2002 - 2017 12

Figure 3: Contraceptives Market, Global, Annual Cost of Usage, ($), 2002 - 2017 14

Figure 4: Contraceptives Market, Global, Share of Prescription and OTC Contraceptives, (%), 2010 15

Figure 5: Contraceptives Market, Global, Drivers and Barriers, 2011 16

Figure 6: Contraceptives Market, The US, Revenue Forecasts, ($bn), 2002 - 2017 17

Figure 7: Contraceptives Market, The US, Annual Cost of Usage, ($), 2002 - 2017 18

Figure 8: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts, ($bn), 2002 - 2017 19

Figure 9: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2002 - 2017 20

Figure 10: Contraceptives Market, Japan, Revenue Forecasts, ($m), 2002 - 2017 21

Figure 11: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2002 - 2017 22

Figure 12: Oral Contraceptives Market, Global, Revenue Forecasts, ($m), 2002 - 2017 23

Figure 13: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 24

Figure 14: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2017 26

Figure 15: Oral Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (Million), 2002 - 2017 27

Figure 16: Injectables Market, Global, Revenue Forecasts, ($m), 2002 - 2017 29

Figure 17: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 30

Figure 18: Injectables Market, Global, Annual Cost of Therapy, ($), 2002 - 2017 32

Figure 19: Injectables Market, Global, Treatment Usage Patterns Forecasts, ('000), 2002 - 2017 33

Figure 20: Topical Contraceptives Market, Global, Revenue Forecasts, ($m), 2002 - 2017 35

Figure 21: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 36

Figure 22: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2017 38

Figure 23: Topical Contraceptives Market, Global, Treatment Usage Patterns Forecasts, ('000), 2002 - 2017 39

Figure 24: Vaginal Ring Market, Global, Revenue Forecasts, ($m), 2002 - 2017 41

Figure 25: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 43

Figure 26: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2002 - 2017 45

Figure 27: Intrauterine Devices Market, Global, Revenue Forecasts, ($m), 2002 - 2017 46

Figure 28: Intrauterine Devices Market, Global, Share of Hormonal and Copper Intrauterine Device, (%), 2010 47

Figure 29: Intrauterine Devices Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 48

Figure 30: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2002 - 2017 50

Figure 31: Condoms Market, Global, Revenue Forecasts, ($m), 2002 - 2017 51

Figure 32: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017 52

Figure 33: Condoms Market, Global, Annual Cost of Usage, ($), 2002 - 2017 54

Figure 34: Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011 55

Figure 35: Contraceptives Market, Global, Market Share Analysis, (%), 2011 60

Figure 36: Contraceptives Market, Global, Bayer Company Profile, 2011 62

Figure 37: Contraceptives Market, Global, Bayer, SWOT Analysis, 2011 63

Figure 38: Contraceptives Market, Global, Johnson & Johnson Company Profile, 2011 64

Figure 39: Contraceptives Market, Global, Johnson & Johnson, SWOT Analysis, 2011 64

Figure 40: Contraceptives Market, Global, Church & Dwight Company Profile, 2011 65

Figure 41: Contraceptives Market, Global, Church & Dwight, SWOT Analysis, 2011 65

Figure 42: Contraceptives Market, Global, Merck Company Profile, 2011 66

Figure 43: Contraceptives Market, Global, Merck, SWOT Analysis, 2011 66

Figure 44: Contraceptives Market, Global, Reckitt Benckiser Company Profile, 2011 67

Figure 45: Contraceptives Market, Global, Reckitt Benckiser, SWOT Analysis, 2011 67

Figure 46: Contraceptives Market, Global, M&A Deals by Year, 2000 - 2011 68

Figure 47: Contraceptives Market, Global, M&A Deals by Value (%), 2000 - 2011 69

Figure 48: Contraceptives Market, Global, M&A Deals by Geography (%), 2000 - 2011 70

Figure 49: Contraceptives Market, Global, M&A Deals by Deal Type (%), 2000 - 2011 71

Figure 50: Contraceptives Market, Global, Deals by Deal Sub-Type (%), 2000 - 2011 72

Figure 51: Contraceptives Market, Global, Licensing Agreements by Year, 2004 - 2011 73

Figure 52: Contraceptives Market, Global, Licensing Agreements by Geography (%), 2004 - 2011 74

Figure 53: Contraceptives Market, Global, Licensing Agreements by Value (%), 2004 - 2011 75

Figure 54: Contraceptives Market, Global, Co-Development Agreements by Year, 2006 - 2011 76

Companies mentioned

Yaz/ Yasmin

Mirena

Nuvaring

Bayer

Johnson & Johnson

Church & Dwight

Merck

Reckitt & Benckiser

To order this report:

Medical Equipment and Supply Industry: Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

Medical Equipment and Supply Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives
2. Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018
3. New Interim Data About Combination Oral Contraceptives
4. Reportlinker Adds Global Contraceptives Industry
5. Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value
6. Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers
7. Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers
8. European Pharmaceutical Market: Strategic Assessments of Leading Suppliers
9. China In Vitro Diagnostics Market Outlook to 2016
10. ChemoMetec and De Novo Software to Co-market NucleoCounter® NC-3000™ and FCS Express 4 Image Cytometry Software
11. Global CNS Drug Market: Strategic Assessments of Leading Suppliers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... -- Governor Andrew M. Cuomo today announced a major expansion ... Western New York . This announcement, made ... includes a major expansion of Athenex,s North American headquarters ... , as well as the creation of a state-of-the-art, ... . The combined projects are expected to yield ...
(Date:2/11/2016)... -- Potrero Medical, Inc., the developer of the Accuryn™ critical ... George M. Rapier, III , MD, to its Board ... WellMed is one of the nation,s largest physician owned practice ... Texas and Florida ... internal medicine practice, he has been instrumental to the company,s ...
(Date:2/11/2016)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the leading ... birth tissues, human skin and bone, and patent-protected processes ... and therapies, announced today that it will present at ... New York , NY.  Parker H. ... , Chief Financial Officer and Chris Cashman , ...
Breaking Medicine Technology:
(Date:2/11/2016)... CA (PRWEB) , ... February 11, 2016 , ... ... extensive experience performing a wide range of cosmetic procedures. Along with performing procedures, ... the efficiency and results of many cosmetic procedures. One of the most common ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... The president ... DoD Military Health System but would shift more of the cost burden to military ... TRICARE-reform plan laid out in the defense budget as including limited quantifiable benefit fixes ...
(Date:2/11/2016)... ... February 11, 2016 , ... Thermi™, a ... is pleased to announce the promotions of Allison Kelly to executive vice president ... to executive vice president of North American capital sales, and Wendy Oseas to ...
(Date:2/11/2016)... NJ (PRWEB) , ... February 11, 2016 , ... ... the call for nominations seeking candidates for the Board of Commissioners. Individuals interested ... passion, skills and experience with diversity of clinical practice settings and across allied ...
(Date:2/11/2016)... ... February 11, 2016 , ... Greenfield Insurance Group in Orange ... assist the people of their local community. The agency pledges to select a ... Their hope is to bring awareness to important local causes with fundraising and ...
Breaking Medicine News(10 mins):